🔎 Trials Near Me

Domov › Ploščatocelični karcinom glave in vratu › Kentucky › Louisville

Klinične študije za Ploščatocelični karcinom glave in vratu v Louisville, KY

11 študij za Ploščatocelični karcinom glave in vratu išče udeležence na lokacijah v Louisville in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC

Vključevanje udeležencevFaza 2/3
  • Site#0111, Louisville
  • Site#0115, Louisville
Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT06788990

Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

Vključevanje udeležencevFaza 2
  • The James Graham Brown Cancer Center at University of Louisville, Louisville
  • UofL Health Medical Center Northeast, Louisville
Starost 18–79 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT04671667

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Vključevanje udeležencevFaza 1
  • Norton Cancer Institute, Louisville
Starost 18 in več · Vsi spoli · Posodobljeno 21. sep. 2026 · NCT05983432

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

Vključevanje udeležencevFaza 2
  • The James Graham Brown Cancer Center at University of Louisville, Louisville
  • UofL Health Medical Center Northeast, Louisville
Starost 18 in več · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT02734537

A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Vključevanje udeležencevFaza 2
  • Norton Cancer Institute, Louisville
Starost 18 in več · Vsi spoli · Posodobljeno 21. avg. 2026 · NCT06769698

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

Vključevanje udeležencevFaza 2
  • Baptist Health Floyd, New Albany · 4 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 17. avg. 2026 · NCT06532279

Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin

Vključevanje udeležencevFaza 3
  • The James Graham Brown Cancer Center at University of Louisville, Louisville
  • UofL Health Medical Center Northeast, Louisville
Starost 18 in več · Vsi spoli · Posodobljeno 17. avg. 2026 · NCT07441681

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Vključevanje udeležencevFaza 1/2
  • Norton Cancer Institute, Louisville
Starost 18 in več · Vsi spoli · Posodobljeno 29. jul. 2026 · NCT04198766

A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors

Vključevanje udeležencevFaza 1/2
  • Norton Cancer Institue Downtown, Louisville
Starost 18 in več · Vsi spoli · Posodobljeno 29. jun. 2026 · NCT06747585

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

Vključevanje udeležencevFaza 1
  • Norton Cancer Institute /ID# 248903, Louisville
Starost 18 in več · Vsi spoli · Posodobljeno 23. jun. 2026 · NCT05005403

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

Vključevanje udeležencevFaza 1/2
  • Research Site 115, Louisville
Starost 18 in več · Vsi spoli · Posodobljeno 21. nov. 2025 · NCT05914116

Študije za Ploščatocelični karcinom glave in vratu v drugih mestih

Druge študije v Louisville

Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.